Your browser doesn't support javascript.
loading
Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes.
Iijima, Yasuhiro; Nakayama, Masafumi; Miwa, Takashi; Yakou, Fumiyoshi; Tomiyama, Hirofumi; Shikuma, Junpei; Ito, Rokuro; Tanaka, Akihiko; Manda, Naoki; Odawara, Masato.
Afiliação
  • Iijima Y; Department of Internal Medicine, Todachuo General Hospital, Japan.
  • Nakayama M; Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital, Japan.
  • Miwa T; Department of Shirakawa Community Medicine, Tokyo Medical University, Japan.
  • Yakou F; Diabetes Center, Manda Memorial Hospital, Japan.
  • Tomiyama H; Cardiovascular Center, Todachuo General Hospital, Japan.
  • Shikuma J; Cooperative Major in Advanced Biomedical Sciences, Joint Graduate School of Tokyo Women's Medical University and Waseda University, Japan.
  • Ito R; Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital, Japan.
  • Tanaka A; Department of Internal Medicine, Todachuo General Hospital, Japan.
  • Manda N; Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital, Japan.
  • Odawara M; Department of Cardiology, Tokyo Medical University Hospital, Japan.
Intern Med ; 62(5): 681-688, 2023.
Article em En | MEDLINE | ID: mdl-36858619
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article